OcuSciences

About:

OcuSciences provides non-invasively detect and monitor retinal metabolic dysfunction.

Top Investors: Ann Arbor SPARK

Description:

OcuSciences is a medical diagnostic device company developing an ocular imaging technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction. The company is focused on the investigation of ocular manifestations of diabetes and therapies aimed at treating them.

Total Funding Amount:

$900000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)ocusciences.com

Founders:

Vic Elner

Number of Employees:

1-10

Last Funding Date:

2009-05-01

IPO Status:

Private

Industries: